170 related articles for article (PubMed ID: 32339235)
21. Narrative review of palliative hypofractionated radiotherapy for high grade glioma.
Saeed H; Tseng YD; Lo SS
Ann Palliat Med; 2021 Jan; 10(1):846-862. PubMed ID: 33040565
[TBL] [Abstract][Full Text] [Related]
22. The Clinical Significance of O
Zhao YH; Wang ZF; Cao CJ; Weng H; Xu CS; Li K; Li JL; Lan J; Zeng XT; Li ZQ
Front Neurol; 2018; 9():127. PubMed ID: 29619003
[TBL] [Abstract][Full Text] [Related]
23. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
[TBL] [Abstract][Full Text] [Related]
24. Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG.
Blumenthal DT; Gorlia T; Gilbert MR; Kim MM; Burt Nabors L; Mason WP; Hegi ME; Zhang P; Golfinopoulos V; Perry JR; Hyun Nam D; Erridge SC; Corn BW; Mirimanoff RO; Brown PD; Baumert BG; Mehta MP; van den Bent MJ; Reardon DA; Weller M; Stupp R
Neuro Oncol; 2017 Aug; 19(8):1119-1126. PubMed ID: 28371907
[TBL] [Abstract][Full Text] [Related]
25. Outcomes in Elderly Patients with Glioblastoma Multiforme Treated with Short-Course Radiation Alone Compared to Short-Course Radiation and Concurrent and Adjuvant Temozolomide Based on Performance Status and Extent of Resection.
Mir T; Pond G; Greenspoon JN
Curr Oncol; 2021 Jun; 28(4):2399-2408. PubMed ID: 34206775
[TBL] [Abstract][Full Text] [Related]
26. Glioblastoma care in the elderly.
Jordan JT; Gerstner ER; Batchelor TT; Cahill DP; Plotkin SR
Cancer; 2016 Jan; 122(2):189-97. PubMed ID: 26618888
[TBL] [Abstract][Full Text] [Related]
27. Glioblastoma in Elderly Patients: Current Management and Future Perspectives.
Minniti G; Lombardi G; Paolini S
Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30857221
[TBL] [Abstract][Full Text] [Related]
28. Is a reduction of radiation dose feasible in patients affected by glioblastoma undergoing radio-chemotherapy according to MGMT promoter methylation status without jeopardizing survival?
Tini P; Nardone V; Pastina P; Marampon F; Sebaste L; Cerase A; Tombolini V; Pirtoli L; Mazzei MA
Clin Neurol Neurosurg; 2019 Sep; 184():105445. PubMed ID: 31325903
[TBL] [Abstract][Full Text] [Related]
29. Radiotherapy plus concurrent or sequential temozolomide for glioblastoma in the elderly: a meta-analysis.
Yin AA; Zhang LH; Cheng JX; Dong Y; Liu BL; Han N; Zhang X
PLoS One; 2013; 8(9):e74242. PubMed ID: 24086323
[TBL] [Abstract][Full Text] [Related]
30. Correlation between O6-methylguanine-DNA methyltransferase and survival in elderly patients with glioblastoma treated with radiotherapy plus concomitant and adjuvant temozolomide.
Minniti G; Salvati M; Arcella A; Buttarelli F; D'Elia A; Lanzetta G; Esposito V; Scarpino S; Maurizi Enrici R; Giangaspero F
J Neurooncol; 2011 Apr; 102(2):311-6. PubMed ID: 20686820
[TBL] [Abstract][Full Text] [Related]
31. PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation: A Randomized Phase II Study: BrUOG 244.
Elinzano H; Glantz M; Mrugala M; Kesari S; Piccioni DE; Kim L; Pan E; Yunus S; Coyle T; Timothy K; Evans D; Mantripragada K; Boxerman J; DiPetrillo T; Donahue JE; Hebda N; Mitchell KM; Rosati KL; Safran H
Am J Clin Oncol; 2018 Feb; 41(2):159-162. PubMed ID: 26658237
[TBL] [Abstract][Full Text] [Related]
32. Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525.
Bell EH; Pugh SL; McElroy JP; Gilbert MR; Mehta M; Klimowicz AC; Magliocco A; Bredel M; Robe P; Grosu AL; Stupp R; Curran W; Becker AP; Salavaggione AL; Barnholtz-Sloan JS; Aldape K; Blumenthal DT; Brown PD; Glass J; Souhami L; Lee RJ; Brachman D; Flickinger J; Won M; Chakravarti A
JAMA Oncol; 2017 Jun; 3(6):784-792. PubMed ID: 28097324
[TBL] [Abstract][Full Text] [Related]
33. Radiotherapy with or without temozolomide in elderly patients aged ≥ 70 years with glioblastoma.
Metcalfe E; Karaoglanoglu O; Akyazici E
Contemp Oncol (Pozn); 2016; 20(3):251-5. PubMed ID: 27647990
[TBL] [Abstract][Full Text] [Related]
34. Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme.
Jastaniyah N; Murtha A; Pervez N; Le D; Roa W; Patel S; Mackenzie M; Fulton D; Field C; Ghosh S; Fallone G; Abdulkarim B
Radiat Oncol; 2013 Feb; 8():38. PubMed ID: 23425509
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant Radiation in Older Patients With Glioblastoma: A Retrospective Single Institution Analysis.
Lee JW; Kirkpatrick JP; McSherry F; Herndon JE; Lipp ES; Desjardins A; Randazzo DM; Friedman HS; Ashley DM; Peters KB; Johnson MO
Front Oncol; 2021; 11():631618. PubMed ID: 33732649
[TBL] [Abstract][Full Text] [Related]
36. Patterns of care and outcomes of chemoradiation versus radiation alone for MGMT promoter unmethylated glioblastoma.
Lee A; Malakhov N; Sheth N; Wang A; Han P; Schreiber D
Clin Neurol Neurosurg; 2018 Jul; 170():127-131. PubMed ID: 29777945
[TBL] [Abstract][Full Text] [Related]
37. Hypofractionated versus standard radiation therapy with or without temozolomide for older glioblastoma patients.
Arvold ND; Tanguturi SK; Aizer AA; Wen PY; Reardon DA; Lee EQ; Nayak L; Christianson LW; Horvath MC; Dunn IF; Golby AJ; Johnson MD; Claus EB; Chiocca EA; Ligon KL; Alexander BM
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):384-9. PubMed ID: 25841623
[TBL] [Abstract][Full Text] [Related]
38. Characterizing benefit from temozolomide in MGMT promoter unmethylated and methylated glioblastoma: a systematic review and meta-analysis.
Alnahhas I; Alsawas M; Rayi A; Palmer JD; Raval R; Ong S; Giglio P; Murad MH; Puduvalli V
Neurooncol Adv; 2020; 2(1):vdaa082. PubMed ID: 33150334
[TBL] [Abstract][Full Text] [Related]
39. Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial.
Malmström A; Grønberg BH; Marosi C; Stupp R; Frappaz D; Schultz H; Abacioglu U; Tavelin B; Lhermitte B; Hegi ME; Rosell J; Henriksson R;
Lancet Oncol; 2012 Sep; 13(9):916-26. PubMed ID: 22877848
[TBL] [Abstract][Full Text] [Related]
40. Hypofractionated radiation therapy versus standard fractionated radiation therapy with concurrent temozolomide in elderly patients with newly diagnosed glioblastoma.
Wang TJC; Wu CC; Jani A; Estrada J; Ung T; Chow DS; Soun JE; Saad S; Qureshi YH; Gartrell R; Saadatmand HJ; Saraf A; Garrett MD; Grubb C; Isaacson SR; Cheng SK; Sisti MB; Bruce JN; Sheth SA; Lassman AB; Iwamoto FM; McKhann GM
Pract Radiat Oncol; 2016; 6(5):306-314. PubMed ID: 26952813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
